These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 19879059)

  • 21. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
    Rangarajan R; Subramanian S; Gopalakrishnan K
    Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
    Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
    Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
    J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
    Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
    Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
    Patil VM; Patel FD; Chakraborty S; Oinam AS; Sharma SC
    Br J Radiol; 2011 May; 84(1001):441-8. PubMed ID: 21511749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
    Gao M; Albuquerque K; Chi A; Rusu I
    Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brachytherapy dose received by bladder and rectum in patients with inoperable cervical cancer: CT-based 3D view.
    Marošević G; Osmić H; Fazlić S; Mileusnić D; Babić J
    Acta Med Acad; 2013; 42(1):83-4. PubMed ID: 23735071
    [No Abstract]   [Full Text] [Related]  

  • 31. A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning.
    Patone H; Souhami L; Parker W; Evans M; Duclos M; Portelance L
    Brachytherapy; 2008; 7(3):254-9. PubMed ID: 18579447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
    Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
    Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
    Hellebust TP; Dale E; Skjønsberg A; Olsen DR
    Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
    Levitchi M; Charra-Brunaud C; Quetin P; Haie-Meder C; Kerr C; Castelain B; Delannes M; Thomas L; Desandes E; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):314-21. PubMed ID: 22633813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
    Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
    Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
    Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.